Tag: immunotherapy
Search News
Scientists uncover protein with the power to help or hinder breast cancer progression
30th April 2024
The findings could help more patients to benefit from the latest advances in immunotherapies.
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more
Dr Luigi Ombrato awarded Cancer Research UK grant to understand how the seeds of secondary tumours grow
21st March 2024
Congratulations to Dr Luigi Ombrato who has been awarded a £700k grant to investigate the earliest stages of cancer spread.
Read more
New drug combination doubles survival for people with bladder cancer
25th October 2023
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Read more
The REMODEL project: Remodelling tumour microenvironments to improve immunotherapy
12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more
In conversation with Professor Marco Gerlinger
20th May 2022
This International Clinical Trials Day, we spoke with Professor Marco Gerlinger. Professor Gerlinger and his team’s laboratory research focuses on understanding and overcoming drug resistance in bowel and gastro-oesophageal cancers, and identifying new and more effective ways to treat these cancers using immunotherapies and combination therapies.
Read more